Last edited Sat Mar 14, 2026, 11:56 PM - Edit history (2)
When you look at the lengthy legislation, search the word 'personal'. It only appears 8 times in the document (the first couple of hits are in a different context).
And then, see below for some added nuance, apropos why this is not in effect, despite being settled law.
MEDICARE PRESCRIPTION DRUG, IMPROVEMENT, AND MODERNIZATION ACT OF 2003
https://www.govinfo.gov/content/pkg/PLAW-108publ173/html/PLAW-108publ173.htm
Excerpt, re: personal importation of prescription medications. [CIPA certification checks all these boxes.]
(3) Drugs imported from Canada.--In
particular, the Secretary shall by regulation grant individuals
a waiver to permit individuals to import into the United States
a prescription drug that--
``(A) is imported from a licensed pharmacy for
personal use by an individual, not for resale, in
quantities that do not exceed a 90-day supply;
``(B) is accompanied by a copy of a valid
prescription;
``(C) is imported from Canada, from a seller
registered with the Secretary;
``(D) is a prescription drug approved by the
Secretary under chapter V;
``(E) is in the form of a final finished dosage that
was manufactured in an establishment registered under
section 510; and
``(F) is imported under such other conditions as the
Secretary determines to be necessary to ensure public
safety.
The excerpt shows that Congress explicitly created a legal framework to permit individuals importing prescription drugs from Canada for personal use.
However, as the text itself indicates, this authority is contingent on the Secretary of Health and Human Services (HHS) first establishing regulations to put the program into effect. This is the critical point where the law on paper meets the reality of implementation.
The Law vs. The Reality: Why the Waiver Isn't Active
The section, specifically (j) Waiver Authority for Importation by Individuals, does several things:
1)
It declares Congressional intent: Congress states that the Secretary "should exercise discretion" to permit personal importation that doesn't pose a public health risk.
2)
It grants authority: It explicitly gives the Secretary the power to grant waivers, either through a general regulation or on a case-by-case basis.
3)
It specifically mandates a regulation for Canadian imports: Paragraph (3) is the key. It says the Secretary "shall by regulation grant individuals a waiver" to import a 90-day supply from a licensed Canadian pharmacy, provided specific safety conditions are met (e.g., a valid U.S. prescription, the drug is FDA-approved, etc.).
This language is mandatory ('shall by regulation'). So, why isn't this program up and running? The answer lies in the actions (and inactions) of subsequent HHS Secretaries.
Despite this law being passed in 2003,
no HHS Secretary has ever issued the final regulations needed to implement Section 1121. This is often referred to as the law being "on the books" but not "in effect." Successive Secretaries from both Republican and Democratic administrations have declined to move forward, citing concerns about the safety and security of the pharmaceutical supply chain, the logistical challenges of implementation, and opposition from the pharmaceutical industry.
Still (so far), FDA chooses not to enforce the law for personal use..
= new reply since forum marked as read